Decrease expression of microRNA-744 promotes cell proliferation by targeting c-Myc in human hepatocellular carcinoma

Cancer Cell International

Volumn 14, Issue 1, 2014, Pages

  Lin, Feng ^a   Ding, Ruliang ^a   Zheng, Shuang ^a   Xing, Dongyi ^a   Hong, Weiwen ^a   Zhou, Zhijun ^b   Shen, Jie ^a  

^a Department of General Surgery Taizhou First People's Hospital   (France)

^b TAIZHOU FIRST PEOPLE S HOSPITAL   (China)

Author keywords

c Myc; Cyclin D1; Hepatocellular carcinoma (HCC); miR 744; Tumor suppressors

Indexed keywords

MICRORNA; MICRORNA 744; MYC PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BIOLOGICAL FUNCTIONS; CELL CYCLE ASSAY; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIVER CELL; LIVER CELL CARCINOMA; LUCIFERASE ASSAY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ADULT; CANCER GROWTH; CELL PROLIFERATION ASSAY; CLINICAL ARTICLE; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN TISSUE; MALE; QUANTITATIVE ANALYSIS; WILD TYPE;

EID: 84902727928     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-14-58     Document Type: Article

References (34)

1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. cell 2004, 116:281-297.
2. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006, 6:857-866.
3. Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Cancer 2009, 10:704-714.
4. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
5. Engels BM, Hutvagner G. Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene 2006, 25:6163-6169.
6. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
7. Xu T, Zhu Y, Xiong Y, Ge Y, Yun J, Zhuang S. MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. Hepatology 2009, 50:113-121.
8. Su H, Yang J-R, Xu T, Huang J, Xu L, Yuan Y, Zhuang S-M. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res 2009, 69:1135-1142.
9. Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S, Liu C-G, Calin GA, Giovannini C, Ferrazzi E, Grazi GL. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 2007, 67:6092-6099.
10. Fornari F, Gramantieri L, Ferracin M, Veronese A, Sabbioni S, Calin GA, Grazi GL, Giovannini C, Croce CM, Bolondi L. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene 2008, 27:5651-5661.
11. Wang Y, Lee ATC, Ma JZI, Wang J, Ren J, Yang Y, Tantoso E, Li K-B, Ooi LLPJ, Tan P. Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. J Biol Chem 2008, 283:13205-13215.
12. Wong QW, Lung RW, Law PT, Lai PB, Chan KY, To K, Wong N. MicroRNA-223 Is commonly repressed in repatocellular carcinoma and potentiates expression of stathmin1. Gastroenterology 2008, 135:257-269.
13. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007, 133:647-658.
14. Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong Q, Qin L, Wu X, Zheng Y, Yang Y. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 2011, 19:232-243.
15. Dong Y, Zhao J, Wu C-W, Zhang L, Liu X, Kang W, Leung W-W, Zhang N, Chan FKL, Sung JJY. Tumor Suppressor Functions of miR-133a in Colorectal Cancer. Mol Cancer Res 2013, 11:1051-1060.
16. Vislovukh A, Kratassiouk G, Porto E, Gralievska N, Beldiman C, Pinna G, Elskaya A, Harel-Bellan A, Negrutskii B, Groisman I. Proto-oncogenic isoform A2 of eukaryotic translation elongation factor eEF1 is a target of miR-663 and miR-744. Br J Cancer 2013, 108:2304-2311.
17. Song M-Y, Pan K-F, Su H-J, Zhang L, Ma J-L, Li J-Y, Yuasa Y, Kang D, Kim YS, You W-C. Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer. PLoS One 2012, 7:e33608.
18. Helwak A, Kudla G, Dudnakova T, Tollervey D. Mapping the Human miRNA Interactome by CLASH Reveals Frequent Noncanonical Binding. Cell 2013, 153:654-665.
19. Secombe J, Pierce SB, Eisenman RN. Myc: a weapon of mass destruction. Cell 2004, 117:153-156.
20. Adhikary S, Eilers M. Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 2005, 6:635-645.
21. Grandori C, Cowley SM, James LP, Eisenman RN. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol 2000, 16:653-699.
22. Pelengaris S, Khan M, Evan G. c-MYC: more than just a matter of life and death. Nat Rev Cancer 2002, 2:764-776.
23. Lin C-P, Liu C-R, Lee C-N, Chan T-S, Liu HE. Targeting c-Myc as a novel approach for hepatocellular carcinoma. World J Hepatol 2010, 2:16-20.
24. Lal A, Navarro F, Maher CA, Maliszewski LE, Yan N, Oday E, Chowdhury D, Dykxhoorn DM, Tsai P, Hofmann O. miR-24 Inhibits Cell Proliferation by Targeting E2F2, MYC, and Other Cell-Cycle Genes via Binding to " Seedless" 3′UTR MicroRNA Recognition Elements. Mol Cell 2009, 35:610-625.
25. Sachdeva M, Zhu S, Wu F, Wu H, Walia V, Kumar S, Elble R, Watabe K, Mo Y-Y. p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci 2009, 106:3207-3212.
26. Sampson VB, Rong NH, Han J, Yang Q, Aris V, Soteropoulos P, Petrelli NJ, Dunn SP, Krueger LJ. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res 2007, 67:9762-9770.
27. Liao J-M, Lu H. Autoregulatory suppression of c-Myc by miR-185-3p. J Biol Chem 2011, 286:33901-33909.
28. Roy AL, Carruthers C, Gutjahr T, Roeder RG. Direct role for Myc in transcription initiation mediated by interactions with TFII-I. Nature 1993, 365:359-361.
29. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006, 6:259-269.
30. Kent OA, Mendell JT. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 2006, 25:6188-6196.
31. Huang V, Place RF, Portnoy V, Wang J, Qi Z, Jia Z, Yu A, Shuman M, Yu J, Li L-C. Upregulation of Cyclin B1 by miRNA and its implications in cancer. Nucleic Acids Res 2011, 40:1695-1707.
32. Arabi A, Wu S, Ridderstråle K, Bierhoff H, Shiue C, Fatyol K, Fahlén S, Hydbring P, Söderberg O, Grummt I, Larsson LG, Wright AP. c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription. Nat Cell Biol 2005, 7:303-310.
33. Grandori C, Gomez-Roman N, Felton-Edkins ZA, Ngouenet C, Galloway DA, Eisenman RN, White RJ. c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nat Cell Biol 2005, 7:311-318.
34. Grewal SS, Li L, Orian A, Eisenman RN, Edgar BA. Myc-dependent regulation of ribosomal RNA synthesis during Drosophila development. Nat Cell Biol 2005, 7:295-302.